Propanc Biopharma, Inc.
Pharmaceutical company · Camberwell, Victoria, Victoria, Australia · Nasdaq: PPCB
Propanc Biopharma, Inc. is a pharmaceutical company headquartered in Camberwell, Victoria, Victoria, Australia. Its earliest recorded incorporation is in 2010. Its shares trade on Nasdaq under the ticker PPCB. It has reported private securities offerings to the US SEC, most recently $40,000 sold in a notice filed in 2023.
Propanc Biopharma at a glance
What does Propanc Biopharma do?
Private fundraising reported to the SEC
15 Form D notices; the most recent reported $40,000 sold (2023).
Frequently asked questions about Propanc Biopharma
Where is Propanc Biopharma headquartered?
Propanc Biopharma, Inc. is headquartered in Camberwell, Victoria, Victoria, Australia.
What does Propanc Biopharma do?
Propanc Biopharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Propanc Biopharma a public company?
Yes. Propanc Biopharma, Inc. trades on Nasdaq under the ticker PPCB.
When was Propanc Biopharma founded?
The earliest incorporation on record for Propanc Biopharma, Inc. is in 2010, according to public company registers.
Similar companies
- Kazia Therapeutics LtdSydney, New South Wales, Australia
- IMMUTEP LtdSydney, New South Wales, Australia
- Radiopharm Theranostics LtdCarlton, Victoria, Australia
- Alterity Therapeutics LtdMelbourne, Victoria, Australia
- Immuron LtdCarlton, Victoria, Australia
- Cyclomedica Australia PTY LtdKingsgrove, New South Wales, Australia
- Botanix Pharmaceuticals Ltd.North Perth, Western Australia, Australia
- Telix Pharmaceuticals LtdNorth Melbourne, Victoria, Australia
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences